Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Traws Pharma, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +6 vs. Q1 2026
- Shares held
- 6.16M
- +2.54M (+70.1%) vs. Q1 2026
- Total value
- $5.19M
- −$1.43M (−21.6%) vs. Q1 2026
- New holders
- 13
- 9 more added
- Sold out
- 7
- 8 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $5.19M |
| Q1 2026 | 28 | $6.62M |
| Q4 2025 | 22 | $3.86M |
| Q3 2025 | 18 | $2.41M |
| Q2 2025 | 19 | $1.87M |
| Q1 2025 | 19 | $3.98M |
| Q4 2024 | 19 | $10.2M |
| Q3 2024 | 12 | $3.80M |
| Q2 2024 | 30 | $1.36M |
| Q1 2024 | 26 | $1.88M |
| Q4 2023 | 27 | $1.35M |
| Q3 2023 | 28 | $1.27M |
| Q2 2023 | 24 | $2.19M |
| Q1 2023 | 25 | $1.04M |
| Q4 2022 | 29 | $1.01M |
| Q3 2022 | 30 | $1.54M |
| Q2 2022 | 32 | $2.36M |
| Q1 2022 | 28 | $3.60M |
| Q4 2021 | 34 | $6.14M |
| Q3 2021 | 37 | $10.5M |
| Q2 2021 | 24 | $10.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Traws Pharma, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2 | $2 | 0.00% | −21−91.3% | Reduced |
| Jones Financial Companies LLLP | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 5 | $4 | 0.00% | +5 | New |
| Cassaday & Co Wealth Management LLC | 6 | $6 | 0.00% | −5−45.5% | Reduced |
| Vanguard Global Advisers, LLC | 262 | $221 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 468 | $395 | 0.00% | −3,261−87.4% | Reduced |
| Federation des caisses Desjardins du Quebec | 500 | $414 | 0.00% | +500 | New |
| SBI Securities Co., Ltd. | 1,721 | $1.45K | 0.00% | +1,593+1,244.5% | Added |
| Barclays PLC | 1,947 | $1.64K | 0.00% | +1,947 | New |
| UBS Group AG | 3,451 | $2.91K | 0.00% | −602−14.9% | Reduced |
| Huntington National Bank | 4,676 | $3.94K | 0.00% | +4,676 | New |
| Tower Research Capital LLC (TRC) | 5,142 | $4.34K | 0.00% | +1,178+29.7% | Added |
| BlackRock, Inc. | 9,941 | $8.38K | 0.00% | −15−0.2% | Reduced |
| Virtu Financial LLC | 12,579 | $11.0K | 0.00% | +12,579 | New |
| SG Americas Securities, LLC | 14,524 | $12.0K | 0.00% | +14,524 | New |
| XTX Topco Ltd | 18,092 | $15.3K | 0.00% | +18,092 | New |
| State Street Corp | 25,802 | $21.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 37,454 | $31.6K | 0.00% | +37,454 | New |
| Vanguard Fiduciary Trust Co | 54,511 | $46.0K | 0.00% | +22,707+71.4% | Added |
| Dauntless Investment Group, LLC | 80,574 | $67.9K | 0.12% | −336,424−80.7% | Reduced |
| Kynam Capital Management, LP | 84,400 | $71.2K | 0.00% | +84,400 | New |
| HRT Financial LP | 91,220 | $76.0K | 0.00% | +91,220 | New |
| Geode Capital Management, LLC | 111,365 | $93.9K | 0.00% | +34,262+44.4% | Added |
| Boothbay Fund Management, LLC | 133,936 | $112.9K | 0.00% | −60,600−31.2% | Reduced |
| Alyeska Investment Group, L.P. | 164,376 | $138.6K | 0.00% | +164,376 | New |
| Jane Street Group, LLC | 216,006 | $182.2K | 0.00% | +194,765+916.9% | Added |
| Vanguard Capital Management LLC | 330,049 | $278.2K | 0.00% | +274,856+498.0% | Added |
| Sphera Funds Management Ltd. | 398,486 | $336.0K | 0.05% | +398,486 | New |
| Ikarian Capital, LLC | 478,142 | $403.2K | 0.07% | −200,000−29.5% | Reduced |
| Lynx1 Capital Management LP | 559,470 | $471.8K | 0.05% | +544,392+3,610.5% | Added |
| ADAR1 Capital Management, LLC | 597,729 | $504.1K | 0.02% | +443,631+287.9% | Added |
| Adage Capital Partners GP, L.L.C. | 730,000 | $615.6K | 0.00% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 786,236 | $663.0K | 0.85% | +786,236 | New |
| OrbiMed Advisors LLC | 1,203,260 | $1.01M | 0.02% | +597,729+98.7% | Added |
| Squadron Capital Management LLC | 0 | $0 | 0.00% | −511,714−100.0% | Sold out |
| Palumbo Wealth Management LLC | 0 | $0 | 0.00% | −61,175−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −19,244−100.0% | Sold out |
| Robinswood Financial LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −6−100.0% | Sold out |